James Wilbur serves as Executive at 10x Genomics, Inc., where they oversee executive responsibilities. Since joining the company, James Wilbur has executed 6 insider transactions totaling $1.2M, demonstrating a bearish approach to their equity position. Their most recent transaction on Nov 22, 2023 involved selling 3,464 shares valued at $150.1K.
James Wilbur currently holds 83,342 shares of 10x Genomics, Inc. (TXG), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James Wilbur has been a net seller of TXG stock. They have purchased $0 and sold $1.2M worth of shares.
James Wilbur's most recent insider trade was on Nov 22, 2023, when they sold 3,464 shares at $43.34 per share.
Get notified when new Form 4 filings are submitted
| $42.09 |
| Discretionary |
| Aug 22, 2023 | TXG | $444.0K | Sale | 9,699 | $45.78 | Discretionary |
| May 23, 2023 | TXG | $17.4K | Sale | 316 | $55.07 | Discretionary |
| Mar 21, 2023 | TXG | $0 | Award | 14,555 | $N/A | Discretionary |
| Sep 14, 2022 | TXG | $0 | Award | 95,839 | $N/A | Discretionary |